NKTR
Nektar TherapeuticsstockNASDAQ
Market OpenNov 19, 2026 9:46:16 AM EST
34.22USD-0.581%(-0.20)18,063
Pre-marketNov 19, 2026 8:51:30 AM EST
34.22USD-0.581%(-0.20)
NKTR Financials
In Q3 FY 2026 (ended ), Nektar Therapeutics (NKTR) reported revenue of $9.39M, net income of −$55.65M, operating cash flow of −$71.93M, and assets of $1.04B (filed ).
Loading financial statements…
